Outcome and risk factors of pediatric hemato-oncology patients admitted in pediatric intensive care unit.
10.3345/kjp.2009.52.10.1153
- Author:
Bo Eun KIM
1
;
Eun Ju HA
;
Keun Wook BAE
;
Seonguk KIM
;
Ho Joon IM
;
Jong Jin SEO
;
Seong Jong PARK
Author Information
1. Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. drpsj@amc.seoul.kr
- Publication Type:Original Article
- Keywords:
Pediatric intensive care units;
Mortality;
Outcome assessment;
Hematology;
Medical oncology;
Respiratory insufficiency;
Septic shock;
C-reactive protein
- MeSH:
C-Reactive Protein;
Dialysis;
Hematologic Diseases;
Hematology;
Hematopoietic Stem Cell Transplantation;
Humans;
Critical Care;
Intensive Care Units;
Intensive Care Units, Pediatric;
Medical Oncology;
Medical Records;
Respiratory Insufficiency;
Retrospective Studies;
Risk Factors;
Shock, Septic;
Terminal Care;
Ventilation
- From:Korean Journal of Pediatrics
2009;52(10):1153-1160
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To evaluate the risk factors for mortality and prognostic factors in pediatric hemato-oncology patients admitted to the pediatric intensive care unit (PICU). METHODS: We retrospectively reviewed the medical records of pediatric hemato-oncology patients admitted at the PICU of the Asan Medical Center between September 2005 and July 2008. Patients admitted at the PICU for perioperative or terminal care were excluded. RESULTS: Total 88 patients were analyzed. Overall ICU mortality rate was 34.1%. Mean age at PICU admission was 7.0+/-5.7 years and mean duration of PICU stay was 18.1+/-22.2 days. Hematologic diseases contributed to 77.3% of all the primary diagnoses, and the primary cause of admission was respiratory failure (39.8%). The factors related to increased mortality were C-reactive protein level (P<0.01), ventilation or dialysis requirement (P<0.01), and hematopoietic stem cell transplantation (P<0.05). In all, 3 scoring systems were investigated [Number of Organ System Failures (OSF number), the Pediatric Risk of Mortality III (PRISM III) score, and the Sequential Organ Failure Assessment (SOFA) score]; higher score correlated with worse outcome (P<0.01). The Oncological Pediatric Risk of Mortality (O-PRISM) scores of the 21 patients who had received hematopoietic stem cell transplantation were higher among the non-survivors, but not statistically significant (P=0.203). CONCLUSION: The PRISM III and SOFA scores obtained within 24 hours of PICU admission were found to be useful as early mortality predictors. The highest OSF number during the PICU stay was closely related to poor outcome.
